UniProt ID | ETV4_HUMAN | |
---|---|---|
UniProt AC | P43268 | |
Protein Name | ETS translocation variant 4 | |
Gene Name | ETV4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 484 | |
Subcellular Localization | Nucleus. | |
Protein Description | Transcriptional activator that binds to the enhancer of the adenovirus E1A gene; the core-binding sequence is 5'[AC]GGA[AT]GT-3'.. | |
Protein Sequence | MERRMKAGYLDQQVPYTFSSKSPGNGSLREALIGPLGKLMDPGSLPPLDSEDLFQDLSHFQETWLAEAQVPDSDEQFVPDFHSENLAFHSPTTRIKKEPQSPRTDPALSCSRKPPLPYHHGEQCLYSSAYDPPRQIAIKSPAPGALGQSPLQPFPRAEQRNFLRSSGTSQPHPGHGYLGEHSSVFQQPLDICHSFTSQGGGREPLPAPYQHQLSEPCPPYPQQSFKQEYHDPLYEQAGQPAVDQGGVNGHRYPGAGVVIKQEQTDFAYDSDVTGCASMYLHTEGFSGPSPGDGAMGYGYEKPLRPFPDDVCVVPEKFEGDIKQEGVGAFREGPPYQRRGALQLWQFLVALLDDPTNAHFIAWTGRGMEFKLIEPEEVARLWGIQKNRPAMNYDKLSRSLRYYYEKGIMQKVAGERYVYKFVCEPEALFSLAFPDNQRPALKAEFDRPVSEEDTVPLSHLDESPAYLPELAGPAQPFGPKGGYSY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Acetylation | --MERRMKAGYLDQQ --CCCCCCCCCCCCC | 36.53 | 21543453 | |
6 | Sumoylation | --MERRMKAGYLDQQ --CCCCCCCCCCCCC | 36.53 | 28112733 | |
16 | Phosphorylation | YLDQQVPYTFSSKSP CCCCCCCCEECCCCC | 22.89 | 23312004 | |
17 | Phosphorylation | LDQQVPYTFSSKSPG CCCCCCCEECCCCCC | 15.80 | 23312004 | |
19 | Phosphorylation | QQVPYTFSSKSPGNG CCCCCEECCCCCCCC | 29.11 | 23312004 | |
20 | Phosphorylation | QVPYTFSSKSPGNGS CCCCEECCCCCCCCC | 32.72 | 23312004 | |
21 | Acetylation | VPYTFSSKSPGNGSL CCCEECCCCCCCCCH | 60.51 | 21543453 | |
22 | Phosphorylation | PYTFSSKSPGNGSLR CCEECCCCCCCCCHH | 39.73 | 23312004 | |
27 | Phosphorylation | SKSPGNGSLREALIG CCCCCCCCHHHHHCC | 28.40 | 23312004 | |
38 | Acetylation | ALIGPLGKLMDPGSL HHCCCHHHHCCCCCC | 48.60 | 21543453 | |
58 | Ubiquitination | EDLFQDLSHFQETWL HHHHHCHHHHHHHHH | 30.46 | 22505724 | |
73 | Phosphorylation | AEAQVPDSDEQFVPD HHCCCCCCCCCCCCC | 36.66 | - | |
96 | Sumoylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | 28112733 | |
96 | Acetylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | 21543453 | |
96 | Ubiquitination | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | PubMed | |
96 | Sumoylation | HSPTTRIKKEPQSPR CCCCCCCCCCCCCCC | 48.03 | - | |
97 | Ubiquitination | SPTTRIKKEPQSPRT CCCCCCCCCCCCCCC | 72.72 | 22505724 | |
101 | Phosphorylation | RIKKEPQSPRTDPAL CCCCCCCCCCCCCCC | 27.37 | 19307308 | |
104 | Phosphorylation | KEPQSPRTDPALSCS CCCCCCCCCCCCCCC | 50.12 | 23312004 | |
109 | Phosphorylation | PRTDPALSCSRKPPL CCCCCCCCCCCCCCC | 16.50 | 23312004 | |
113 | Acetylation | PALSCSRKPPLPYHH CCCCCCCCCCCCCCC | 34.39 | 21543453 | |
139 | Acetylation | PPRQIAIKSPAPGAL CCCEEEEECCCCCCC | 41.17 | 21543453 | |
140 | Phosphorylation | PRQIAIKSPAPGALG CCEEEEECCCCCCCC | 21.85 | 25159151 | |
149 | Phosphorylation | APGALGQSPLQPFPR CCCCCCCCCCCCCCH | 26.27 | 25159151 | |
214 | Phosphorylation | APYQHQLSEPCPPYP CCCCCCCCCCCCCCC | 32.68 | - | |
226 | Sumoylation | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | - | |
226 | Sumoylation | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | 25755297 | |
226 | Ubiquitination | PYPQQSFKQEYHDPL CCCCCCHHHHHCCHH | 47.68 | PubMed | |
260 | Sumoylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | - | |
260 | Acetylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | 21543453 | |
260 | Sumoylation | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | - | |
260 | Ubiquitination | PGAGVVIKQEQTDFA CCCEEEEEECCCCCC | 35.85 | PubMed | |
301 | Acetylation | AMGYGYEKPLRPFPD CCCCCCCCCCCCCCC | 40.65 | 21543453 | |
316 | Acetylation | DVCVVPEKFEGDIKQ CEEECCCCCCCCCCC | 42.52 | 21543453 | |
322 | Sumoylation | EKFEGDIKQEGVGAF CCCCCCCCCCCCCCH | 47.22 | - | |
322 | Sumoylation | EKFEGDIKQEGVGAF CCCCCCCCCCCCCCH | 47.22 | - | |
392 | Phosphorylation | KNRPAMNYDKLSRSL CCCCCCCHHHHHHHH | 11.02 | 26657352 | |
396 | Phosphorylation | AMNYDKLSRSLRYYY CCCHHHHHHHHHHHH | 26.09 | 26657352 | |
398 | Phosphorylation | NYDKLSRSLRYYYEK CHHHHHHHHHHHHHH | 17.52 | 25954137 | |
416 | Phosphorylation | QKVAGERYVYKFVCE HHHCCCCEEEEEEEC | 12.11 | - | |
441 | Acetylation | DNQRPALKAEFDRPV CCCCCCCCCCCCCCC | 48.23 | 21543453 | |
441 | Sumoylation | DNQRPALKAEFDRPV CCCCCCCCCCCCCCC | 48.23 | - | |
449 | Phosphorylation | AEFDRPVSEEDTVPL CCCCCCCCHHHCCCH | 37.64 | 23898821 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ETV4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HXD4_HUMAN | HOXD4 | physical | 20211142 | |
A4_HUMAN | APP | physical | 21832049 | |
STK11_HUMAN | STK11 | physical | 21150337 | |
STK11_HUMAN | STK11 | physical | 16912160 | |
JUN_HUMAN | JUN | physical | 16786139 | |
CARM1_HUMAN | CARM1 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140 AND SER-149, ANDMASS SPECTROMETRY. | |
Sumoylation | |
Reference | PubMed |
"Extracellular signal-regulated kinase mitogen-activated proteinkinase signaling initiates a dynamic interplay between sumoylation andubiquitination to regulate the activity of the transcriptionalactivator PEA3."; Guo B., Sharrocks A.D.; Mol. Cell. Biol. 29:3204-3218(2009). Cited for: FUNCTION, SUMOYLATION AT LYS-96; LYS-226 AND LYS-260, DESUMOYLATION BYSENP1, UBIQUITINATION BY RNF4, DEUBIQUITINATION BY UPS2, ANDMUTAGENESIS OF LYS-96; GLU-98; SER-101; PRO-102; LYS-226; GLU-228;LYS-260; GLU-262; GLU-324 AND GLU-443. |